2
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Immunotherapy in type I diabetes

Approaches to prevention and treatment

, MBBS, MD & , MD, PhD
Pages 146-155 | Published online: 16 May 2016

References

  • Eisenbarth GS. Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 1986: 314(21): 1360–8
  • Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965:14(10): 619–33
  • Jackson RA, Morris MA, Haynes BF, et al. Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. N Engl J Med 1982: 306(13): 785–8
  • Sutherland DE, Sibley R, Chinn P, et al. Twin-to-twin pancreas transplantation (tx): reversal and reenactment of the pathogenesis of type I diabetes. (Abstr) Clin Res 1984: 32(2): 561 A
  • Srikanta S, Ganda OP, Eisenbarth GS, et al. Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for type I diabetes mellitus. N Engl J Med 1983: 308(6): 322–5
  • Cobb WE, Molitch M, Reichlin S. Levamisole in insulin-dependent diabetes mellitus. (Letter) N Engl J Med 1980: 303(18): 1065–6
  • Leslie RD, Pyke DA. Immunosuppression of acute insulin dependent diabetes. In: Irvine WJ, ed. Immunology of diabetes. Edinburgh: Teviot Scientific Publications. 1980: 345–7
  • Rand KH, Rosenbloom AL, Maclaren NK, et al. Human leukocyte interferon treatment of two children with insulin dependent diabetes. Diabetologia 1981: 21(2): 116–9
  • Elliott RB, Crossley JR. Berryman CC, et al. Partial preservation of pancreatic beta-cell function in children with diabetes. Lancet 1981: 2(8236): 1–4
  • Eisenbarth GS, Srikanta S, Jackson R, et al. Antt-thymocyte globulin and prednisone immunotherapy of recent onset type I diabetes mellitus. Diabetes Res 1985: 2(6): 271–6
  • Ludvigsson J, Heding L, Lieden G, et al. Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children. Br Med J (Clin Res) 1983: 286(6360): 176–8
  • Harrison LC, Colman PG, Dean B. et al. Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine. Diabetes 1985: 34(12): 1306–8
  • Silverstein J, Riley W, Spillar R, et al. A trial of immunosuppression with imuran in insulin dependent diabetes. (Abstr) Diabetes 1986: 35(Suppl 1): 5A
  • Stiller CR, Dapre J, Gent M, et al. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 1984: 223(4643): 1362–7
  • Feutren G, Papoz L, Assan R, et al. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset: results of multicentre double-blind trial. Lancet 1986: 2(8499): 119–24
  • Myers BD, Ross J, Newton L, et al. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984: 311(11): 699–705
  • Beveridge T, Krupp P, McKibbin C. Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy. (Letter) Lancet 1984:1(8380): 788
  • Srikanta S, Rablzadeh A, Omar MA, et al. Assay for islet cell antibodies: protein A—monoclonal antibody method. Diabetes 1985: 34(3): 300–5
  • Bottazzo GF, Dean BM, Gorauch AN, et al. Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage. Lancet 1980: 1(8170): 668–72
  • Colman PG, Nayak RC, Connelly J, et al. Islet cell antibodies: clinical utility and target antigen(s). New York: Elsevier Science Publishing (in press)
  • Maclaren NK, Riley WJ, Harne G, et al. Pancreatic islet cell antibodies to predict insulin dependent diabetes in US schoolchildren. Lancet (in press)
  • Vardi P, Tuttleman M, Grinbeigs M, et al. Constancy of anti-islet autoimmunity in “pre-type 1 diabetics” and genetically susceptible subjects: evidence from an ultrasensitive competitive insulin autoantibody (CIAA) radioimmunoassay. (Abstr) Diabetes 1986:35(Suppl 1): 86A
  • Rossini AA, Williams RM, Appel MC, et al. Complete protection from low-dose streptozotocin-induced diabetes in mice. Natur 1978:276(5684): 182–4
  • Yamada K, Nonaka K, Hanafosa T, et al. Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis: an observation in nonobese diabetic (NOD) mice. Diabetes 1982: 31(9): 749–53
  • Cohen IR. prospects for the treatment of immunological diseases. Clin Immunol Allergy 1984:4(3): 593–605

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.